Esperion Therapeutics (Acquired) Overview
- Year Founded
-
1998
- Status
-
Acquired/Merged
- Employees
-
21
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$5M
Esperion Therapeutics (Acquired) General Information
Description
Developer of pharmaceutical products for the treatment of cardiovascular and metabolic diseases. The company engages in research, development, and commercialization of oral, low-density lipoprotein cholesterol lowering therapies for the treatment of patients with hypercholesterolemia and other cardiometabolic risk markers.
Contact Information
Corporate Office
- 46701 Commerce Center Drive
- Suite B
- Plymouth, MI 48170
- United States
Corporate Office
- 46701 Commerce Center Drive
- Suite B
- Plymouth, MI 48170
- United States
Esperion Therapeutics (Acquired) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Merger/Acquisition | 28-Apr-2008 | $5M | Completed | Clinical Trials - Phase 2 | ||
| 5. Merger/Acquisition | 01-Jan-2004 | Completed | Clinical Trials - Phase 2 | |||
| 4. IPO | 10-Aug-2000 | Completed | Clinical Trials - Phase 2 | |||
| 3. Later Stage VC (Series C) | 13-Jan-2000 | Completed | Startup | |||
| 2. Early Stage VC | $6.2M | Completed | Startup | |||
| 1. Debt - General | 08-Nov-1999 | $6.2M | $6.2M | Completed | Startup |
Esperion Therapeutics (Acquired) Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Esperion Therapeutics (Acquired) Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Esperion Therapeutics (Acquired) Former Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Canaan Partners | Venture Capital | Minority | ||
| HealthCap | Venture Capital | Minority | ||
| Oak Investment Partners | Venture Capital | Minority | ||
| Pfizer | Corporation | Minority | ||
| Scheer & Company | Venture Capital | Minority |
Esperion Therapeutics (Acquired) FAQs
-
When was Esperion Therapeutics (Acquired) founded?
Esperion Therapeutics (Acquired) was founded in 1998.
-
Where is Esperion Therapeutics (Acquired) headquartered?
Esperion Therapeutics (Acquired) is headquartered in Plymouth, MI.
-
What is the size of Esperion Therapeutics (Acquired)?
Esperion Therapeutics (Acquired) has 21 total employees.
-
What industry is Esperion Therapeutics (Acquired) in?
Esperion Therapeutics (Acquired)’s primary industry is Drug Discovery.
-
Is Esperion Therapeutics (Acquired) a private or public company?
Esperion Therapeutics (Acquired) is a Private company.
-
What is the current valuation of Esperion Therapeutics (Acquired)?
The current valuation of Esperion Therapeutics (Acquired) is .
-
What is Esperion Therapeutics (Acquired)’s current revenue?
The current revenue for Esperion Therapeutics (Acquired) is .
-
How much funding has Esperion Therapeutics (Acquired) raised over time?
Esperion Therapeutics (Acquired) has raised $82.2M.
-
Who are Esperion Therapeutics (Acquired)’s investors?
Canaan Partners, HealthCap, Oak Investment Partners, Pfizer, and Scheer & Company are 5 of 7 investors who have invested in Esperion Therapeutics (Acquired).
-
When was Esperion Therapeutics (Acquired) acquired?
Esperion Therapeutics (Acquired) was acquired on 28-Apr-2008.
-
Who acquired Esperion Therapeutics (Acquired)?
Esperion Therapeutics (Acquired) was acquired by Esperion Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
